hrp0094p1-136 | Growth Hormone and IGFs A | ESPE2021

Comparison of actual GH dose with labeled dose in children with short stature based on the LG Growth Study

Lee Hae Sang , Chung Sochung , Rhie Young-Jun , Kim Jae Hyun , Chae Hyun-Wook , Choi Jin Ho , Lee Young Ah , Kim Yoo-Mi , Hwang Il Tae ,

Objectives: This study aimed to analyze dosing patterns of recombinant human growth hormone (rhGH) (Eutropin® Inj\., Eutropin®Pen Inj., and Eutropin®AQ Inj. for daily injection, and Eutropin®Plus Inj. for weekly injection, LG Chem, Ltd.) using the collected data of the LG Growth Study (LGS) in Korean pediatric patients with growth disorders including growth hormone deficiency (GHD), idiopathic sho...

hrp0097fc11.1 | GH and IGFs | ESPE2023

GH replacement therapy with once-weekly somapacitan in children with GH deficiency is effective and well-tolerated: 2-year results from REAL4

Miller Bradley , Blair Joanne , Højby Rasmussen Michael , Maniatis Aristides , Mori Jun , Böttcher Volker , Bang Rikke , Polak Michel , Horikawa Reiko

Daily subcutaneous (s.c.) injections of growth hormone (GH) to treat GH deficiency (GHD) in children is burdensome for both patients and caregivers. Somapacitan (Novo Nordisk) is a long-acting reversible albumin-binding human GH derivative in development for once-weekly s.c. administration in children with GHD, and aims to overcome the treatment burden of daily injections. REAL4 is a multi-national, randomised, open labelled phase 3 trial with a 52-week main phase followed by ...

hrp0097fc14.5 | Late Breaking | ESPE2023

Predicting Average IGF-I Concentration for Once-Weekly Somapacitan in Children with Growth Hormone Deficiency

F. Backeljauw Philippe , Kamal Lyauk Yassine , C. Blair Joanne , S. Miller Bradley , Mori Jun , Højby Rasmussen Michael , Juul Kildemoes Rasmus

Growth hormone (GH) stimulates insulin like growth factor I (IGF I) release. IGF-I is the standard biomarker for monitoring GH effects during treatment and to achieve optimal long-term safety, and to a limited extent, monitor efficacy in children with GH deficiency (GHD). The IGF I profile during treatment with a long acting GH (LAGH), such as once weekly somapacitan (Novo Nordisk), differs from the daily GH profile by exhibiting larger peaks and troughs over the dosing interv...

hrp0097p1-100 | GH and IGFs | ESPE2023

Exploring healthcare professionals’ attitudes towards digitalization and the perceived usefulness and ease of use of digital solutions in patients receiving growth hormone therapy: Results of a Korean participatory study

Wook Chae Hyun , Rivera Romero Octavio , Kun Cheon Chong , Sang Lee Hae , Kim Jihyun , Eun Moon Jung , Koledova Ekaterina , Sil Oh Eun , Yang Yoo-Jin , Rhie Young-Jun

Background: Aluetta® Smartdot™ (Merck Healthcare KGaA, Darmstadt, Germany) is a novel injection device for administering recombinant-human growth hormone (r-hGH), integrated with a smart knob attachment for data transmission that combines ease of use with advanced capabilities. Integration with Growzen™ digital ecosystem empowers healthcare professionals (HCPs) with remote monitoring of patient adherence, thereby promoting optimal cl...

hrp0097p2-258 | Late Breaking | ESPE2023

Long-term Safety and Effectiveness of Growth Hormone in Pediatric Patients with Growth Disorders in Korea: A 10-Year Interim Analysis of the LG Growth Study

Sang Lee Hae , Chung Sochung , Rhie Young-Jun , Hyun Kim Jae , Chae Hyun-Wook , Ho Choi Jin , Ah Lee Young , Mi Kim Yoo , Tae Hwang Il

Objectives: This study aimed to evaluate the safety and effectiveness of rhGH treatment, using specific products (Eutropin®, Eutropin®Pen, Eutropin®AQ, Eutropin®Plus and Eutropin®SPen; LG Chem, Ltd.), in pediatric patients with growth disorders in Korea.Methods: Among the patients who enrolled in LGS (2012–2022, n=5,120), patients received at least one injection of rhGH were included fo...

hrp0092t20 | Top 20 Poster | ESPE2019

Molecular and Phenotypic Spectrum of Noonan Syndrome in Chinese Patients

Li Xin , Yao Ruen , Tan Xin , Li Niu , Ding Yu , Li Juan , Chang Guoying , Chen Yao , Ma Lizhuang , Wang Jian , Fu Lijun , Wang Xiumin

Background: Noonan syndrome (NS) is a common autosomal dominant/recessive disorder. No large-scale study has been conducted on NS in China, which is the most populous country in the world.Methods: Next-generation sequencing (NGS) was used to identify pathogenic variants in patients that exhibited NS-related phenotypes. We assessed the facial features and clinical manifestations of patients with pathogenic or likely patho...

hrp0089p3-p344 | Sex Differentiation, Gonads and Gynaecology or Sex Endocrinology P3 | ESPE2018

A Case Report: A Girl with 46,XY Karyotype and Disorder of Androgen Synthesis

Šuput Omladič Jasna , Bertok Sara , Žerjav Tanšek Mojca , Kovač Jernej , Battelino Tadej , Hartmann Michaela F. , Wudy Stefan A , Avbelj Stefanija Magdalena

Background: Disorders of androgen synthesis are rare causes of 46,XY disorder of sex development (DSD) that present with undervirilization or sex reversal.Objective: A history of a female adolescent with 46,XY DSD, initially suspected to have complete androgen insensitivity is presented.Methods: Patient history was obtained from the medical records. Urinary steroid profile was preformed using gas chromatography/mass spectrometry. T...

hrp0095p1-66 | Fat, Metabolism and Obesity | ESPE2022

Effect of gender and age on the mental well-being and self-esteem of adolescents living with obesity: subanalysis from the ACTION Teens global study

Pedro López Siguero Juan , A. Baur Louise , Bereket Abdullah , Bin-Abbas Bassam , Chen Walter , Fernández-Aranda Fernando , Garibay Nieto Nayely , C.G. Halford Jason , Maffeis Claudio , Mooney Vicki , Karenina Osorto Cynthia , Reynoso Ricardo , Rhie Young-Jun , Toro-Ramos Martín

Background: The ACTION Teens study aimed to identify attitudes, behaviours and perceptions among adolescents living with obesity (ALwO), caregivers of ALwO (CGs) and healthcare professionals (HCPs) who treat ALwO. This subanalysis assessed the mental well-being and self-esteem of ALwO.Methods: ACTION Teens was a global, cross-sectional study (NCT05013359) that surveyed 5275 ALwO (aged 12–<18 years), 5389 CGs and...

hrp0095p1-67 | Fat, Metabolism and Obesity | ESPE2022

Effect of unawareness of obesity on perceptions of obesity and food/diet among adolescents living with obesity and their caregivers: subanalysis from the ACTION Teens global study

Bereket Abdullah , A. Baur Louise , Bin-Abbas Bassam , Chen Walter , Fernández-Aranda Fernando , Garibay Nieto Nayely , C.G. Halford Jason , Pedro López Siguero Juan , Maffeis Claudio , Mooney Vicki , Karenina Osorto Cynthia , Reynoso Ricardo , Rhie Young-Jun , Toro-Ramos Martín

Background: This subanalysis of the ACTION Teens study aimed to explore perceptions of obesity and food/diet among adolescents living with obesity (ALwO) and caregivers of ALwO (CGs) who were unaware of their/their child’s obesity.Methods: The global, cross-sectional ACTION Teens survey study (NCT05013359) assessed perceptions, attitudes and behaviours among 5275 ALwO (aged 12–<18 years), 5389 CGs and 2323...

hrp0092fc5.6 | Thyroid | ESPE2019

Homozygous Loss-of-Function Mutation in the SLC26A7 Gene Coding a Novel Iodide Transporter Causes Goitrous Congenital Hypothyroidism

Suzuki Atsushi , Ishii Jun , Yoshida Aya , Yamguchi Naoya , Tanaka Tatsushi , Aoyama Kohei , Tateyama Michihiro , Chen I-Shan , Kubo Yoshihiro , Kimura Toru , Yazawa Takuya , Arimasu Yu , Kamma Hiroshi , Saitoh Shinji , Mizuno Haruo

Introduction: Iodide transport in the thyroid is crucial for thyroid hormone synthesis. A homozygous loss-of-function mutation in the SLC26A4gene coding an iodide transporter located at the apical side in the thyroid follicular cells causes Pendred syndrome accompanied with goitrous congenital hypothyroidism (CH) and sensorineural deafness. However, about half of patients with Pendred syndrome demonstrate normal thyroid function. This indicates anothe...